This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Schering Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2006-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,409 
1 out of 387 
Years Active: 2006-2012
Title: Uwe Mueller: Innovator in Pharmaceutical Chemistry
Introduction
Uwe Mueller is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for synthesizing complex chemical compounds. With a total of 3 patents to his name, his work has had a considerable impact on the pharmaceutical industry.
Latest Patents
One of Uwe Mueller's latest patents is a method for preparing 4-[17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-dien-11β-yl]benzaldehyde (E)-oxime, also known as asoprisnil. This invention focuses on a reliable and reproducible preparation method that is suitable for both pilot and manufacturing scales. Asoprisnil is characterized by excellent physical stability, making it particularly suitable for the production of solid pharmaceutical forms such as tablets and coated tablets.
Another significant patent involves a process for the production of crystals of 11β-benzaldoxim-estra-4,9-diene derivatives. This process includes subjecting a supersaturated solution containing a specific 11β-benzaldoxim-estra-4,9-diene derivative to wet milling while crystallizing. The resulting crystals, which have an average particle size ranging from 3 μm to 25 μm, are also described in the patent, along with pharmaceutical preparations that incorporate them.
Career Highlights
Throughout his career, Uwe Mueller has worked with prominent companies in the pharmaceutical sector, including Schering AG and Bayer Pharma AG. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Uwe has collaborated with notable professionals in his field, including Detlef Grawe and Hagen Gerecke. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Uwe Mueller's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence the development of effective pharmaceutical products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile